Esomeprazole magnesium hydrate
SIGMA/E7906 - ≥98% (HPLC)
Synonym: (S)-Omeprazole magnesium hydrate; (T-
CAS Number: 668985-31-7
Empirical Formula (Hill Notation): C34H36MgN6O6S2 · xH2O
Molecular Weight: 713.12 (anhydrous basis)
MDL Number: MFCD11226784
Linear Formula: C34H36MgN6O6S2 · xH2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/2C17H18N3O3S.Mg.H2O/c2 |
| InChI key | LGRFYKXKCZKDLS-DIYDTZFBSA |
| optical activity | [α]/D -128 to -146°, c = 0.5 in methanol |
| originator | AstraZeneca |
| Quality Level | 100 ![]() |
| SMILES string | O.COc1ccc2n([Mg]n3c(nc4cc |
| solubility | DMSO: ≥5 mg/mL |
| storage temp. | 2-8°C |
| Application: | Esomeprazole magnesium hydrate has been used to induce intracellular acidification in an ATP12A-independent manner. |
| Biochem/physiol Actions: | Esomeprazole magnesium dihydrate is a leading proton pump inhibitor. |
| Features and Benefits: | This compound was developed by AstraZeneca . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Esomeprazole is the (S)-isomer of omeprazole. It blocks the H+/K+-ATPase enzyme and lowers the release of hydrochloric acid by gastric parietal cells. Esomeprazole is used for treating gastroesophageal reflux disease (GERD). |
| Packaging: | 50, 250 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


